Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
Aerie Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Aerie Pharmaceuticals reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, eight executives at Aerie Pharmaceuticals received on average a compensation package of $1.9M, a 10% increase compared to previous year.
Average pay of disclosed executives at Aerie Pharmaceuticals
Vicente Anido, Jr., Chief Executive Officer, received $3.8M in total, which increased by 4% compared to 2020. 39% of Anido's compensation, or $1.5M, was in option awards. Anido also received $581K in salary, $494K in stock awards, as well as $1.2M in other compensation.
Raj Kannan, Chief Executive Officer, received a compensation package of $3.5M. 50% of the compensation package, or $1.8M, was in option awards.
Thomas A. Mitro, Chief Operating Officer, earned $1.7M in 2021, a 8% decrease compared to previous year.
Casey C. Kopczynski, Chief Innovation Officer, Head of Research and External Innovation, received $1.5M in 2021, which decreases by 2% compared to 2020.
John W. LaRocca, General Counsel, earned $1.5M in 2021, a 54% increase compared to previous year.
Benjamin F. McGraw, III, Former Interim Executive Chair, received $1.3M in 2021.
Richard J. Rubino, Chief Financial Officer, earned $1.3M in 2021, a 24% decrease compared to previous year.
Christopher Staten, Chief Financial Officer, received $532K in 2021.
Related executives
Raj Kannan
Aerie Pharmaceuticals
Chief Executive Officer
Casey Kopczynski
Aerie Pharmaceuticals
Chief Innovation Officer, Head of Research and External Innovation
John LaRocca
Aerie Pharmaceuticals
General Counsel
Benjamin McGraw
Aerie Pharmaceuticals
Former Interim Executive Chair
Thomas Mitro
Aerie Pharmaceuticals
Chief Operating Officer
Vicente Anido
Aerie Pharmaceuticals
Chief Executive Officer
Richard Rubino
Aerie Pharmaceuticals
Chief Financial Officer
Christopher Staten
Aerie Pharmaceuticals
Chief Financial Officer
You may also like
Source: SEC filing on April 26, 2022.